Eevia Health Plc receives a 587 KSEK (51 KEUR) sales order for a Bilberry extract product
Eevia Health Plc ("Eevia" or "The Company") has received a 51 KEUR sales order from a European nutraceutical brand owner.
The customer is a European brand owner headquartered in Sweden. The customer develops and markets effective herbal dietary supplements and cosmetics in over 50,000 pharmacies, health food shops, and other retail outlets across 38 countries, including China and the USA.
This new order's sales value to Eevia is c. 51 KEUR for Feno-Myrtillus® 1, a bilberry extract standardized for anthocyanins. This is a repeat order and one of the few brand holders of Eevia services without using a distributor. The business has developed, with repeat orders over the last few years. Eevia was selected due to its high quality and product authenticity.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
Eevia Health manufactures 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.